Ashish Vig, CEO, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies)
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ashish Vig, CEO, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies), discusses how digital health platforms are transforming India’s healthcare through improved access, AI-driven efficiency, and proactive care. He emphasizes the role of e-pharmacies in ensuring compliance, building trust, strengthening supply chains, and enabling a connected, patient-centric healthcare ecosystem.
Ashish Vig is a seasoned business leader with 17 years of experience in digital health, e-commerce, and business strategy. He specializes in building scalable businesses, driving monetization, and leading sales and distribution, with strong expertise in innovation, partnerships, and market expansion.
As digital health platforms rapidly grow in India, transforming patient access, how do you see this shift impacting healthcare delivery and patient outcomes?
The rapid growth of digital health platforms in India is fundamentally reshaping healthcare from a reactive system to a more proactive and accessible one. We are seeing a clear shift where geography is no longer a constraint. Patients in Tier 2 and Tier 3 cities now have access to qualified doctors, diagnostics, and medicines in ways that were previously unimaginable.
More importantly, digital platforms are improving continuity of care. With integrated patient records, e- prescriptions, and follow ups, outcomes are becoming more consistent and measurable. The real impact, however, lies in early intervention. Patients are engaging sooner, which reduces disease progression and overall healthcare costs.
In essence, digital health is not just improving access. It is democratizing quality healthcare while driving better clinical outcomes at scale.
Also Read: Pharmaceutical Procurement Strategies: How to Optimize Costs
With AI and machine learning transforming healthcare and improving diagnosis accuracy, how do you foresee these technologies enhancing digital health efficiency and overcoming adoption challenges?
AI and machine learning are becoming central to how we think about efficiency and accuracy in healthcare. From improving diagnostic precision to enabling personalized treatment pathways, these technologies are already delivering tangible value. AI is no longer artificial; it’s Augmented Intelligence.
For digital health platforms, AI helps streamline operations, whether it is demand forecasting, fraud detection, or optimizing supply chains. On the patient side, AI-driven tools such as symptom checkers and adherence reminders are enhancing engagement and outcomes.
That said, adoption challenges remain, particularly around trust, explainability, and regulatory clarity. To overcome this, we need to focus on transparent AI models, robust clinical validation, and strong collaboration with regulators. Ultimately, technology must augment not replace the clinician, and that is how we build confidence in the ecosystem.
Digital health is transforming India’s healthcare from reactive to proactive, breaking geographic barriers and enabling early intervention, consistent care, and improved outcomes at scale.
As telemedicine adoption accelerates across India and regulatory challenges remain, what steps can e-pharmacies take to navigate these hurdles and ensure compliance in this evolving landscape?
The regulatory landscape in India is evolving, and rightly so, given the sensitivity of healthcare. For e- pharmacies, the priority must be to stay ahead of compliance rather than react to it. This means building systems that ensure prescription validation, traceability of medicines, and adherence to data privacy norms. We also need strong partnerships with licensed pharmacies and healthcare providers to ensure accountability across the value chain.
Equally important is engaging constructively with policymakers. As an industry, we must contribute to shaping frameworks that balance innovation with patient safety. Those who invest early in compliance infrastructure will not only mitigate risk but also build long term credibility.
In the e-pharmacy sector, trust and data security are increasingly crucial as patient concerns grow. What steps can platforms take to enhance protection and foster lasting relationships?
Trust is the currency of digital healthcare. Without it, scale is meaningless. Patients are sharing highly sensitive information, so platforms must adopt a privacy first approach. End to end encryption, secure data storage, and strict access controls are non-negotiable. Beyond technology, transparency plays a big role. Patients should clearly understand how their data is used and protected. Another dimension of trust is authenticity. Ensuring that medicines are genuine, sourced from verified channels, and delivered with integrity is critical. Combining this with responsive customer support and pharmacist access creates a more human experience.
In the long run, trust is built not just through compliance, but through consistently doing the right thing for the patient
Given recent supply chain disruptions affecting many sectors, how can e-pharmacies innovate logistics and stock management to meet growing demand while ensuring timely medication delivery?
Supply chain resilience has become a strategic priority for e-pharmacies. The key is moving from linear supply chains to intelligent, technology enabled networks. We are increasingly leveraging data analytics for demand forecasting, enabling better inventory planning and reducing stockouts.
Distributed warehousing and micro fulfillment centers are helping us get closer to the customer, improving delivery timelines. Technology also plays a role in real-time tracking and cold chain management for sensitive medicines. At the same time, partnerships with local pharmacies and logistics providers create a hybrid model that is both scalable and resilient.
Ultimately, the goal is to ensure that critical medications reach patients reliably, because in healthcare, delays can have serious consequences.
Also Read: Advanced Formulation Technologies Streamlining Global Pharma Innovation
Looking ahead, as digital health holds immense potential to revolutionize patient care, what innovations do you foresee in this space, and how can e-pharmacies contribute?
Looking ahead, digital health in India is poised for a significant leap. We will see deeper integration across the ecosystem. Consultations, diagnostics, pharmacies, and insurance will come together to create a seamless patient journey.
Personalization will be a major trend, driven by data and AI. Tailored treatment plans, predictive healthcare, and preventive care models will become more mainstream. Wearables and remote monitoring will further shift care from hospitals to homes. E-pharmacies will play a critical role in this ecosystem, not just as medicine delivery platforms, but as comprehensive health partners. From chronic care management to medication adherence programs and health analytics, the scope is expanding rapidly.
In many ways, we are moving toward a model where healthcare is continuous, connected, and patient-centric, and e-pharmacies will be at the heart of enabling that transformation.